Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

In vitro lytic activity and antifungal susceptibility of infrequently isolated yeasts.

Montoya AM, Luna-Rodríguez CE, Gracia-Robles G, Rojas OC, González GM.

Arch Microbiol. 2019 Oct;201(8):1147-1149. doi: 10.1007/s00203-019-01684-2. Epub 2019 May 30.

PMID:
31147748
2.

Candida and candidaemia. Susceptibility and epidemiology.

Arendrup MC.

Dan Med J. 2013 Nov;60(11):B4698. Review.

PMID:
24192246
3.

In vitro virulence determinants, comparative pathogenicity of Diutina (Candida) mesorugosa clinical isolates and literature review of the D. rugosa complex.

Montoya AM, Luna-Rodríguez CE, Gracia-Robles G, Rojas OC, Treviño-Rangel RJ, González GM.

Mycologia. 2019 May-Jun;111(3):395-407. doi: 10.1080/00275514.2019.1585161. Epub 2019 Apr 15.

PMID:
30985256
4.

Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital.

Posteraro B, Spanu T, Fiori B, De Maio F, De Carolis E, Giaquinto A, Prete V, De Angelis G, Torelli R, D'Inzeo T, Vella A, De Luca A, Tumbarello M, Ricciardi W, Sanguinetti M.

Antimicrob Agents Chemother. 2015 Jul;59(7):3944-55. doi: 10.1128/AAC.00285-15. Epub 2015 Apr 20.

5.

[Investigation of antifungal susceptibilities and some virulence factors of Candida strains isolated from blood cultures and genotyping by RAPD-PCR].

Gültekin B, Eyigör M, Tiryaki Y, Kırdar S, Aydın N.

Mikrobiyol Bul. 2011 Apr;45(2):306-17. Turkish.

PMID:
21644074
6.

Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates.

Simitsopoulou M, Peshkova P, Tasina E, Katragkou A, Kyrpitzi D, Velegraki A, Walsh TJ, Roilides E.

Antimicrob Agents Chemother. 2013 Jun;57(6):2562-70. doi: 10.1128/AAC.02541-12. Epub 2013 Mar 25.

8.

Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in Candida and Aspergillus Species for the Sensititre YeastOne Colorimetric Broth and Etest Agar Diffusion Methods.

Espinel-Ingroff A, Turnidge J, Alastruey-Izquierdo A, Botterel F, Canton E, Castro C, Chen YC, Chen Y, Chryssanthou E, Dannaoui E, Garcia-Effron G, Gonzalez GM, Govender NP, Guinea J, Kidd S, Lackner M, Lass-Flörl C, Linares-Sicilia MJ, López-Soria L, Magobo R, Pelaez T, Quindós G, Rodriguez-Iglesia MA, Ruiz MA, Sánchez-Reus F, Sanguinetti M, Shields R, Szweda P, Tortorano A, Wengenack NL, Bramati S, Cavanna C, DeLuca C, Gelmi M, Grancini A, Lombardi G, Meletiadis J, Negri CE, Passera M, Peman J, Prigitano A, Sala E, Tejada M.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01651-18. doi: 10.1128/AAC.01651-18. Print 2019 Jan.

9.

Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?

Kovacicova G, Krupova Y, Lovaszova M, Roidova A, Trupl J, Liskova A, Hanzen J, Milosovic P, Lamosova M, Macekova L, Szovenyiova Z, Purgelova A, Obertik T, Bille J, Krcmery V.

J Infect Chemother. 2000 Dec;6(4):216-21.

PMID:
11810569
11.

Molecular Identification and Antifungal Susceptibility Pattern of Non-albicans Candida Species Isolated from Vulvovaginal Candidiasis

Abbasi Nejat Z, Farahyar S, Falahati M, Ashrafi Khozani M, Hosseini AF, Faiazy A, Ekhtiari M, Hashemi-Hafshenjani S.

Iran Biomed J. 2017 Jul 9;22(1):33-41. Epub 2018 Jan 1.

12.

Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study.

Schmalreck AF, Willinger B, Haase G, Blum G, Lass-Flörl C, Fegeler W, Becker K; Antifungal Susceptibility Testing-AFST Study Group.

Mycoses. 2012 May;55(3):e124-37. doi: 10.1111/j.1439-0507.2011.02165.x. Epub 2012 Jan 11.

PMID:
22233267
13.

Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.

Krcmery V, Barnes AJ.

J Hosp Infect. 2002 Apr;50(4):243-60. Review.

PMID:
12014897
14.

Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry.

Aslani N, Janbabaei G, Abastabar M, Meis JF, Babaeian M, Khodavaisy S, Boekhout T, Badali H.

BMC Infect Dis. 2018 Jan 8;18(1):24. doi: 10.1186/s12879-017-2916-5.

15.

Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.

Samaranayake YH, Samaranayake LP, Tsang PC, Wong KH, Yeung KW.

J Oral Pathol Med. 2001 Jul;30(6):336-46.

PMID:
11459319
16.

[Biofilm production and antifungal susceptibility patterns of Candida species].

Yücesoy M, Karaman M.

Mikrobiyol Bul. 2004 Jan-Apr;38(1-2):91-8. Turkish.

PMID:
15293907
17.
19.

Influence of subinhibitory antifungal concentrations on extracellular hydrolases and biofilm production by Candida albicans recovered from Egyptian patients.

El-Houssaini HH, Elnabawy OM, Nasser HA, Elkhatib WF.

BMC Infect Dis. 2019 Jan 16;19(1):54. doi: 10.1186/s12879-019-3685-0.

20.

[Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital].

Skrodeniene E, Dambrauskiene A, Vitkauskiene A.

Medicina (Kaunas). 2006;42(4):294-9. Lithuanian.

Supplemental Content

Support Center